Antitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo

References

• DamronTAWardWGStewartAOsteosarcoma, chondrosarcoma, and Ewing’s sarcoma: National Cancer Data Base ReportClin Orthop Relat Res2007459404717414166
   PubMed Web of Science ®Google Scholar
• FerrariSPalmeriniEAdjuvant and neoadjuvant combination chemotherapy for osteogenic sarcomaCurr Opin Oncol200719434134617545797
   PubMed Web of Science ®Google Scholar
• AndersonMEUpdate on Survival in OsteosarcomaOrthop Clin North Am201647128329226614941
   PubMed Web of Science ®Google Scholar
• FerrariSSerraMAn update on chemotherapy for osteosarcomaExpert Opin Pharmacother201516182727273626512909
   PubMed Web of Science ®Google Scholar
• RatanRPatelSRChemotherapy for soft tissue sarcomaCancer2016122192952296027434055
   PubMed Web of Science ®Google Scholar
• ShaikhABLiFLiMPresent advances and future perspectives of molecular targeted therapy for osteosarcomaInt J Mol Sci201617450627058531
   PubMed Web of Science ®Google Scholar
• NewmanDJCraggGMNatural products as sources of new drugs from 1981 to 2014J Nat Prod201679362966126852623
   PubMed Web of Science ®Google Scholar
• De SanctisRMarrariASantoroATrabectedin for the treatment of soft tissue sarcomasExpert Opin Pharmacother201617111569157727328277
   PubMed Web of Science ®Google Scholar
• AkihisaTTokudaHIchiishiEAnti-tumor promoting effects of multiflorane-type triterpenoids and cytotoxic activity of karounidiol against human cancer cell linesCancer Lett2001173191411578803
   PubMedGoogle Scholar
• BannoNAkihisaTYasukawaKAnti-inflammatory activities of the triterpene acids from the resin of Boswellia carteriJ Ethnopharmacol2006107224925316621377
   PubMed Web of Science ®Google Scholar
• YanYYBaiJPXieYYuJZMaCGThe triterpenoid pristimerin induces U87 glioma cell apoptosis through reactive oxygen species-mediated mitochondrial dysfunctionOncol Lett20135124224823255929
   PubMedGoogle Scholar
• ByunJYKimMJEumDYReactive oxygen species-dependent activation of Bax and poly(ADP-ribose) polymerase-1 is required for mitochondrial cell death induced by triterpenoid pristimerin in human cervical cancer cellsMol Pharmacol200976473474419574249
   PubMedGoogle Scholar
• YangHLandis-PiwowarKRLuDPristimerin induces apoptosis by targeting the proteasome in prostate cancer cellsJ Cell Biochem2008103123424417541980
   PubMedGoogle Scholar
• GaoXLiuYDeebDArbabASGautamSCAnticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-kappaB/mTOR signalingJ Exp Ther Oncol201410427528325509983
   PubMedGoogle Scholar
• MuXShiWSunLLiHJiangZZhangLPristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activationMolecules20121766854686822669041
   PubMedGoogle Scholar
• XieGYuXLiangHPristimerin overcomes adriamycin resistance in breast cancer cells through suppressing Akt signalingOncol Lett20161153111311627123073
   PubMedGoogle Scholar
• MaSLiuXYaoYEffect of temozolomide on cell viability in gonadotroph adenoma cell linesOncol Rep201126354355021617871
   PubMedGoogle Scholar
• MoriYTerauchiRShiraiTSuppression of heat shock protein 70 by siRNA enhances the antitumor effects of cisplatin in cultured human osteosarcoma cellsCell Stress Chaperones Epub201752
   PubMedGoogle Scholar
• WuCCChanMLChenWYTsaiCYChangFRWuYCPristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via direct effects on mitochondriaMol Cancer Ther2005481277128516093444
   PubMedGoogle Scholar
• HanahanDWeinbergRAThe hallmarks of cancerCell20001001577010647931
   PubMed Web of Science ®Google Scholar
• DasariSTchounwouPBCisplatin in cancer therapy: molecular mechanisms of actionEur J Pharmacol201474036437825058905
   PubMed Web of Science ®Google Scholar
• DenaultJBSalvesenGSCaspases: keys in the ignition of cell deathChem Rev2002102124489450012475198
   PubMedGoogle Scholar
• WongRSApoptosis in cancer: from pathogenesis to treatmentJ Exp Clin Cancer Res2011308721943236
   PubMed Web of Science ®Google Scholar
• PolivkaJJrJankuFMolecular targets for cancer therapy in the PI3K/AKT/mTOR pathwayPharmacol Ther2014142216417524333502
   PubMed Web of Science ®Google Scholar
• LiuPChengHRobertsTMZhaoJJTargeting the phosphoinositide 3-kinase pathway in cancerNat Rev Drug Discov20098862764419644473
   PubMed Web of Science ®Google Scholar
• BrownJSBanerjiUMaximising the potential of AKT inhibitors as anti-cancer treatmentsPharmacol Ther201717210111527919797
   PubMed Web of Science ®Google Scholar
• BrasierARThe NF-kappaB regulatory networkCardiovasc Toxicol20066211113017303919
   PubMed Web of Science ®Google Scholar
• CoussensLMWerbZInflammation and cancerNature2002420691786086712490959
   PubMed Web of Science ®Google Scholar
• KarinMNuclear factor-kappaB in cancer development and progressionNature2006441709243143616724054
   PubMed Web of Science ®Google Scholar
• HussainARAhmedSOAhmedMCross-talk between NFkB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosisPLoS One201276e3994522768179
   PubMed Web of Science ®Google Scholar
• DeebDGaoXLiuYThe inhibition of cell proliferation and induction of apoptosis in pancreatic ductal adenocarcinoma cells by verrucarin A, a macrocyclic trichothecene, is associated with the inhibition of Akt/NF-κB/mTOR prosurvival signalingInt J Oncol20164931139114727573873
   PubMedGoogle Scholar
• Eisenberg-LernerABialikSSimonHUKimchiALife and death partners: apoptosis, autophagy and the cross-talk between themCell Death Differ200916796697519325568
   PubMed Web of Science ®Google Scholar
• BurrisHA3rdOvercoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathwayCancer Chemother Pharmacol201371482984223377372
   PubMed Web of Science ®Google Scholar
• HeLWuYLinLHispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathwayCancer Sci2011102121922521087351
   PubMedGoogle Scholar
• TangQLXieXBWangJGlycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcomaJ Natl Cancer Inst20121041074976322534782
   PubMedGoogle Scholar
• YousefBAHassanHMGuerramMPristimerin inhibits proliferation, migration and invasion, and induces apoptosis in HCT-116 colorectal cancer cellsBiomed Pharmacother20167911211927044819
   PubMedGoogle Scholar
• WangLNWangYLuYPristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivoJ Integr Med2014121203424461592
   PubMedGoogle Scholar
• LuZJinYChenCLiJCaoQPanJPristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-AblMol Cancer2010911220482842
   PubMed Web of Science ®Google Scholar